Emil Pharmaceutical Industries Pvt. Ltd., founded in 1989, is a veteran player in the manufacturing and marketing of pharmaceutical and nutraceutical formulations. Headquartered in Mumbai, India, Emil leverages extensive experience to provide a broad portfolio of over 250+ formulations across 20 therapeutic categories.
The company's slogan, "Empower Motivate Inspire Life by making affordable healthcare products globally accessible for all," aligns with its mission and emphasizes its commitment to affordability and accessibility. With established manufacturing capabilities, Emil's two main units cater to a combined volume of ~3.3Bn Tablets, 1.8Bn Capsules, and 42Mn Dry Powder Packs annually, with further expansion expected by 2025.
Emil showcases strong international reach, with products registered across Central & South America, CIS countries, Africa & Middle East, and Asia. The recent INR 1.20B investment by Somerset Indus Capital Partners in April 2023 underscores investor confidence in its growth and operational resilience.